Skip to content

Public FDA record

Z-0831-03: MaxForce TTS High Performance Esophageal Balloon Dilatation Catheter 8mm/24 Fr

Recall record Z-0831-03 for Boston Scientific Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0831-03
Company in FDA record
Boston Scientific Corporation
FDA classification date
May 15, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Catheter is mislabeled as 8 mm/24 Fr instead of a 6 mm/18 Fr

Source facts

Action
The firm notified each direct account by letter on 4/29/03 and, via letters of July 3 and July 11, 2003, extended the recall to three additional sizes of the catheter . Users were requested to check inventory, return the products to Boston Scientific and to reply regarding receipt of recall notification and the return of products.
Initiated
2003-04-29
Root cause
Other
Terminated
2004-03-11
Distribution
CA, CO, IL, FL, HI, KY, LA, MA, ME, MI, NC, OH, PA, SC, TN, UT, VA, WA, WV,
Recall number
Z-0831-03
Recall status
Terminated
CDRH record ID
27261
FDA classified
2003-05-15
Recall event number
26206

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗